Levamisole is a medication that can help with certain types of worms. It's also been studied for other conditions, like arthritis, but it can cause side effects like nausea and low blood counts. It's usually taken by mouth.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Levamisole is a deworming medicine that also changes how the immune system behaves. In countries where it is still sold for people, sometimes under brand names such as Decaris, it is used as a single-dose treatment for intestinal roundworm (ascariasis) and for mixed roundworm and hookworm infections. Its most important current use in people is in children with steroid-sensitive nephrotic syndrome, a kidney condition in which the kidneys leak large amounts of protein into the urine, causing swelling. Steroids usually bring it under control, but some children relapse again and again or relapse whenever steroids are lowered. International pediatric kidney guidelines list levamisole as one of several steroid-sparing options for these children, meaning it is used to keep the condition in remission so they need fewer courses of steroids. In the US, levamisole is no longer available as a human medicine. It was once approved there, together with the chemotherapy drug fluorouracil, after surgery for colon cancer, but the US Food and Drug Administration (FDA) withdrew its approval for human use in 2000 because of severe side effects. Levamisole products sold in the US today are veterinary dewormers for livestock. Many people also encounter the name because levamisole is frequently mixed into illicit cocaine.
In worms, levamisole acts on nicotinic acetylcholine receptors, the switches that tell their muscles to contract. Overstimulating them paralyzes susceptible worms, which can no longer hold on to the intestinal wall and are carried out of the body by normal bowel movements, usually within a day. In people, levamisole also influences the immune system, with effects that can both stimulate and dampen immune responses. Exactly why this helps keep nephrotic syndrome in remission is not well understood. The same immune effects are thought to underlie its most serious harms, which affect white blood cells and blood vessels.
Levamisole for people is taken by mouth as a tablet, and the dose is based on body weight. For roundworm or hookworm, it is usually given as one dose; in a severe hookworm infection, a second dose may be given a week later. For nephrotic syndrome, the plan is quite different. Levamisole is started after steroids have brought the condition into remission and is then taken every other day for many months, often a year or longer. Some specialists continue a low dose of prednisolone on the days in between for the first few months before stopping the steroid. The prescribing kidney team sets the dose and schedule. Veterinary levamisole products are made for animals and should never be taken by people. Their strength and form differ from human tablets, and a fatal human overdose of a veterinary product has been reported.
A single dose for worms is usually well tolerated. Nausea, vomiting, diarrhea, stomach pain, dizziness and headache are the most common complaints. With longer use, as in nephrotic syndrome, rash, a mild drop in white blood cells and abnormal liver tests are the most common problems; these usually settle once levamisole is stopped. The most serious risk is agranulocytosis, a sudden, severe loss of the white blood cells that fight infection. It is uncommon but can be fatal. Fever, a sore throat, mouth sores or any other sign of infection while taking levamisole should prompt a call to the care team right away, because a blood count is needed to check for it. Levamisole can also cause inflammation of blood vessels (vasculitis). This may show up as joint pain or swelling, a new rash, or purple or dark patches on the skin, especially on the ears, arms or legs. These signs also need prompt contact with the care team. In people taking levamisole as a medicine, this reaction has resolved after the drug was stopped.
Levamisole is generally not used in people who already have a blood disorder, who have severe kidney impairment or rheumatoid arthritis, or who are pregnant or breastfeeding, because it has harmed developing embryos in animal studies. It is used with caution in people with liver disease, epilepsy or Sjögren's syndrome. Drinking alcohol while taking levamisole can cause a reaction like that of disulfiram, an alcohol-deterrent drug, which can bring on flushing, nausea and other unpleasant symptoms. Levamisole can make phenytoin, a seizure medicine, more likely to cause toxic effects. It also changes how much of two other deworming drugs, albendazole and ivermectin, reaches the bloodstream, so a prescriber should know about any of these. Levamisole is a common adulterant in illicit cocaine and has also been found in other street drugs, including heroin and fentanyl. People who use these drugs can develop the same agranulocytosis and skin and blood vessel damage described above without knowing they were exposed. Telling a clinician about recent drug use helps them recognize the cause, because routine drug tests do not look for levamisole.
For a worm infection, treatment is usually a single dose, and the worms are expelled over the following day or so. Some side effects, such as nausea or dizziness, may be noticed briefly. For nephrotic syndrome, the goal is fewer relapses and less steroid exposure rather than a cure. In a placebo-controlled trial in children who relapsed often or depended on steroids, about one in four children taking levamisole stayed relapse-free for a full year, compared with about one in seventeen on placebo. Across the group, relapses were somewhat less frequent on levamisole. It seems to work better in children who relapse frequently than in those who relapse as soon as steroids are reduced. Because of the risks to white blood cells, liver and blood vessels, guidelines recommend a blood count and liver tests every three to four months during treatment, and a blood test for ANCA (antineutrophil cytoplasmic antibodies, markers linked to vasculitis) before starting and every six to twelve months. Treatment is stopped if ANCA becomes positive. Once a child has stayed in remission without steroids for at least a year, stopping levamisole without tapering may be considered. Levamisole is inexpensive and does not damage the kidneys, but it is not available in every country, including the US.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Levamisole, what you've noticed, or ask the community a question.